All Notes

Small Colony Variants: Introduction, Morphology, Pathogenicity, Lab Diagnosis, Treatment, Prevention, and Keynotes

Introduction

Small Colony Variants (SCVs) are a subpopulation of bacteria that grow slowly and form unusually small colonies on culture media. They are most commonly described in Staphylococcus aureus, but also occur in Pseudomonas aeruginosa, Escherichia coli, and Listeria monocytogenes. SCVs are associated with chronic, recurrent, and persistent infections due to their altered metabolism and ability to evade host immunity and antibiotics.

Fig. Small Colony Variants of Staphylococcus saprophyticus on CLED agar

Do the above colonies of bacteria, S. saprophyticus, show Small Colony Variants (SCVs)?
Yes. Here is why:

S. NoFeaturesObservationSCV Indicator?
1.Colony sizeSome colonies are significantly smallerYes
2.Growth mediumCLED supports E. coli, Staphylococcus, Enterococcus, Klebsiella, etc.SCVs can form here
3.ColorYellow colonies suggest lactose fermentationColor alone doesn’t rule out SCVs
4.Heterogeneous populationBoth large and very small coloniesCharacteristic of mixed SCV and wild-type

Morphology

  • Colonies are pinpoint-sized, non-pigmented, and often non-hemolytic
  • Grow more slowly than typical strains
  • May require supplementation (e.g., hemin, menadione, thymidine) depending on auxotrophy
  • Under microscope: no distinct morphological difference from wild-type strains

Pathogenicity

  • SCVs exhibit reduced metabolic activity, allowing intracellular persistence
  • They evade immune responses by surviving within host cells (e.g., epithelial cells, macrophages)
  • Known to cause chronic and device-associated infections like:
    • Osteomyelitis
    • Endocarditis
    • Chronic lung infections (especially in cystic fibrosis)
    • Prosthetic joint infections
  • Resistant to many antibiotics, especially those targeting active cell division

Laboratory Diagnosis

  1. Culture:
    • Tiny, slow-growing colonies on blood or nutrient agar
    • Non-pigmented and often missed without prolonged incubation (48–72 hrs)
  2. Auxotrophy testing:
    • SCVs may require hemin, menadione, or thymidine for optimal growth
  3. Biochemical tests:
    • Reduced hemolysis, coagulase activity (in staphylococci)
  4. Molecular diagnostics:
    • PCR or WGS to confirm identity and resistance genes
  5. Electron microscopy (research): May show altered cell wall thickness

Treatment

  • SCVs are difficult to eradicate due to intracellular survival and slow growth
  • Antibiotics with intracellular activity are preferred:
    • Rifampicin, clindamycin, linezolid, trimethoprim-sulfamethoxazole
  • Prolonged antibiotic courses are often needed
  • Combination therapy may help prevent reversion to wild-type and resistance
  • Device removal (e.g., catheter, prosthesis) is often required for cure

Prevention

  • Minimize prolonged antibiotic exposure that may select for SCVs
  • Maintain strict aseptic techniques during device insertion and surgery
  • Regular monitoring in patients with chronic infections (e.g., CF, osteomyelitis)
  • Infection control in healthcare settings, especially in long-term care units

Keynotes

  • SCVs are a phenotypic variant, not a separate species
  • Common in chronic, relapsing infections, especially involving biofilms and intracellular niches
  • Often auxotrophic for essential growth factors like hemin or thymidine
  • Misidentification or underdetection can delay proper treatment
  • Require prolonged and targeted therapy for successful eradication
  • Associated with antibiotic tolerance rather than classical resistance

Further Readings

  • https://www.nature.com/articles/nrmicro1384
  • https://journals.asm.org/doi/10.1128/cmr.00069-15
  • https://pubmed.ncbi.nlm.nih.gov/21253898/
  • https://clsjournal.ascls.org/content/early/2023/04/10/ascls.2020002691
  • https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2019.00363/full
  • https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-023-02611-4
  • https://academic.oup.com/labmed/article/54/3/227/6758443
  • https://onlinelibrary.wiley.com/doi/full/10.1002/jcla.24121
  • https://journals.sagepub.com/doi/10.4137/MBI.S25800
  • https://www.mdpi.com/2079-6382/12/9/1446
  • https://www.nature.com/articles/s41467-018-06527-0
  • https://link.springer.com/article/10.1007/s12223-010-0089-3
  • https://www.jstor.org/stable/4460563
  • https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2014.00099/full
  • https://journals.asm.org/doi/10.1128/jcm.02861-13
Medical Lab Notes

Recent Posts

BACTEC MGIT 960: Introduction, Principle, Procedure, Result-Interpretation, Application, and Keynotes

Introduction The system consists of an incubator-reader that can hold up to 960 culture tubes (7 ml…

10 hours ago

Glass Beads in TB Lab: Introduction, Function, Uses, and Keynotes

Introduction to Glass Beads In a Tuberculosis (TB) laboratory, glass beads are essential tools primarily…

10 hours ago

SIRE Supplement: Introduction, Composition and Function, Uses, and Keynotes

Introduction The BACTEC™ MGIT™ 960 SIRE Supplement is an essential enrichment used specifically for drug susceptibility testing…

1 day ago

OADC Supplement: Introduction, Composition and Function, Uses, and Keynotes

Introduction Middlebrook OADC Growth Supplement is a vital enrichment used in microbiology to support the fastidious growth…

1 day ago

PANTA Supplement: Introduction, Composition and Function, Uses, and Keynotes

Introduction In microbiology and Tuberculosis (TB) diagnostics, PANTA is an antimicrobial supplement used to prevent the overgrowth…

2 days ago

Acinetobacter haemolyticus-Introduction, Morphology, Pathogenicity, Lab Diagnosis, Treatment, Prevention, and Keynotes

Introduction Acinetobacter haemolyticus is an aerobic, non-fermenting bacterium found in nature and hospital environments. It belongs…

4 days ago